Hims & Hers Shares Drop 10% Amid FTC Data and Billing Lawsuit

Hims & Hers Health, Inc. experienced a significant 10% drop in its stock value following a lawsuit filed by the Federal Trade Commission (FTC). The lawsuit, filed on June 26, 2024, accuses the telehealth company of engaging in deceptive practices related to consumer health data sharing, billing, and subscription cancellations. The FTC's complaint specifically details allegations that Hims & Hers shared sensitive user health information with third-party advertising platforms, including Meta and Snap, without adequate consent. This alleged data sharing is a violation of the FTC Act and potentially other privacy regulations, as it involves the disclosure of personal health details obtained through its online platform. The company offers services ranging from prescription medications for hair loss and erectile dysfunction to mental health support and skincare treatments.

Furthermore, the FTC's lawsuit targets Hims & Hers for its billing practices, asserting that the company misled consumers about subscription costs and made it difficult to cancel recurring charges. According to the FTC, Hims & Hers advertised low monthly prices but then automatically renewed subscriptions at higher rates, often without clear disclosure or easy cancellation mechanisms. The complaint states that the company's subscription model and cancellation policies were designed to trap consumers into ongoing payments, a practice that the FTC aims to prevent. The agency is seeking to stop these alleged violations and obtain monetary relief for consumers who were harmed by the company's actions.

In response to the lawsuit, Hims & Hers has stated its commitment to protecting customer privacy and complying with all applicable laws. The company maintains that it has robust data security measures in place and that its practices are transparent. However, the FTC's filing highlights a growing concern among regulators regarding the handling of sensitive personal and health data by digital health platforms and the transparency of subscription-based business models. The outcome of this lawsuit could have implications for other companies operating in the direct-to-consumer telehealth and wellness sectors, potentially leading to increased scrutiny of their data privacy policies and billing procedures. The FTC's action underscores the importance of obtaining explicit consent for data sharing and ensuring clear, accessible cancellation processes for subscription services.